94
Participants
Start Date
August 31, 2016
Primary Completion Date
June 30, 2018
Study Completion Date
June 30, 2018
Naproxen
Subjects enrolled in the active treatment arm will receive 500mg of Naproxen prescribed twice daily, once in the morning and evening.
Omeprazole
Subjects enrolled in the active treatment arm will receive 20mg of Omeprazole prescribed twice daily, once in the morning and evening. Furthermore, subjects should take this one hour before a meal.
Placebo
Subjects enrolled in the inactive treatment arm will receive two prescriptions, however, there are no active ingredients and are intended to look identical to the active treatment. Therefore, subjects will be instructed exactly the same way as if they were ingesting the active treatment.
Northwestern University Feinberg School of Medicine, Chicago
National Center for Complementary and Integrative Health (NCCIH)
NIH
National Institutes of Health (NIH)
NIH
Apkar Apkarian
OTHER